Related Experiment Video
Updated: Apr 18, 2026

Methods to Assess Beta Cell Death Mediated by Cytotoxic T Lymphocytes
Published on: June 16, 2011
Type II anti-CD20 mAb-induced lysosome mediated cell death is mediated through a ceramide-dependent pathway
Hua Ren1, Chengwei Zhang1, Liwei Su1
1Department of Thoracic Surgery, General Hospital of Armed Police Forces, 69 Yongding Road, Beijing 100039, PR China.
Abstract:
In the past decade, monoclonal antibodies (mAbs) have revolutionized the treatment of non-Hodgkin lymphomas (NHLs). Although Fc-dependent mechanisms of mAb-mediated tumor clearance have been extensively studied, the ability of mAbs to directly evoke programmed cell death (PCD) and the underlying mechanisms involved remain unclear. It is well established that type II anti-CD20 mAb (Tositumomab) potently evoked PCD through a caspases-independent, lysosome-mediated process, which is related to homotypic adhesion (HA) in NHL cell lines. Herein, we reveal that the induction of ceramide generation by anti-CD20 mAbs directly correlates with their ability to induce PCD. The inhibition of ceramide abrogated Tositumomab-induced PCD indicating that ceramide is required for the execution of cell death. Further experimental results revealed that ceramide was generated downstream of mAb-induced HA and upstream of lysosome leakage. These findings provide further insights into a previously unrecognized role for ceramide generation in mediating PCD evoked by type II anti-CD20 mAbs in Burkitt's lymphoma cells. This newly characterized cell death pathway may potentially be exploited to eliminate malignant cells.
Insights
Type II anti-CD20 monoclonal antibodies (mAbs) induce programmed cell death (PCD) in lymphoma cells. Ceramide generation, downstream of homotypic adhesion, is essential for this caspase-independent cell death pathway.
Area of Science:
- Immunology
- Cell Biology
- Oncology
Background:
- Monoclonal antibodies (mAbs) have transformed non-Hodgkin lymphoma (NHL) treatment.
- Mechanisms of mAb-induced programmed cell death (PCD) remain incompletely understood.
- Type II anti-CD20 mAbs, like Tositumomab, induce PCD via a caspases-independent, lysosome-mediated pathway linked to homotypic adhesion (HA).
Purpose of the Study:
- To elucidate the role of ceramide generation in mAb-induced PCD.
- To investigate the molecular mechanisms linking homotypic adhesion, ceramide, and cell death.
Main Methods:
- Utilized anti-CD20 mAbs in NHL cell lines.
- Assessed programmed cell death (PCD) induction.
- Investigated ceramide generation, homotypic adhesion (HA), and lysosome integrity.
- Employed ceramide inhibition to determine its necessity in cell death.
Main Results:
- Ceramide generation directly correlated with the ability of anti-CD20 mAbs to induce PCD.
- Inhibiting ceramide производство abrogated Tositumomab-induced PCD, confirming ceramide's essential role.
- Ceramide was generated downstream of mAb-induced HA and upstream of lysosome leakage.
Conclusions:
- Ceramide generation is a critical mediator of PCD induced by type II anti-CD20 mAbs.
- This pathway involves mAb-induced homotypic adhesion, followed by ceramide production and lysosome leakage.
- This newly identified cell death pathway offers a potential target for eliminating malignant cells.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
The Extrinsic Apoptotic Pathway
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cellular Injury V: Apoptosis and Autophagy

